# Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

> **NCT03031535** · PHASE1 · COMPLETED · sponsor: **Dauntless Pharmaceuticals** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Intranasal octreotide acetate
- **DRUG:** Subcutaneous octreotide acetate
- **DIAGNOSTIC_TEST:** Growth hormone-releasing hormone
- **DIAGNOSTIC_TEST:** Arginine hydrochloride

## Key facts

- **NCT ID:** NCT03031535
- **Lead sponsor:** Dauntless Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03031535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03031535, "Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03031535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*